GKWIM
GSK icon

Gerber Kawasaki Wealth & Investment Management’s GSK GSK Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-848
Closed -$40K – 614
2021
Q3 		$40K Buy
+848
New +$42.6K 0.01% 351

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's GSK Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of GSK (GSK) in Q4 2021, closing a stake of 848 shares — an estimated $40K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in GSK in Q3 2021 and held it in 1 quarter. The position peaked at $40K in Q3 2021. 920 funds tracked by Wall St. Rank hold GSK as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining GSK position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 848 GSK shares in Q4 2021, an estimated $40K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in GSK in Q3 2021 and held it in 1 quarter.
  • Gerber Kawasaki Wealth & Investment Management's GSK position peaked at $40K in Q3 2021.
  • 920 funds tracked by Wall St. Rank held GSK as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.